← All reports

The FDA has faced significant challenges in rebuilding its workforce and maintaining regulatory effectiveness after the cuts caused by DOGE.

HealthcareLegal IssuesPoliticsWorkplace ImpactMay 7, 2026score 0.172 posts · 0 replies across 1 instances
The thread discusses the impact of DOGE's cuts on the FDA, with former agency staffers sharing their experiences and the challenges faced during the rebuilding process. It highlights the loss of expertise and the ongoing efforts to recover from these cuts.

Claims

The FDA has faced significant challenges in rebuilding its workforce and maintaining regulatory effectiveness after the cuts caused by DOGE.
Parent: Healthcare RegulationEntity: FDAImpact: negativeDate: May 7, 2026Target: The effectiveness of the FDA in maintaining regulatory standards post-DOGE cuts

Source posts

@[email protected]
What was lost at the FDA: A year after DOGE’s cuts, six agency staffers describe the work they never thought they’d leave. https://www.statnews.com/2026/05/07/fda-rebuilding-after-doge-former-regulators-speaking-out/
0 boosts · 0 favs · 0 replies · May 7, 2026
@[email protected]
What was lost at the FDA. A year after DOGE’s cuts, six FDA staffers describe the work they never thought they’d leave. https://www.statnews.com/2026/05/07/fda-rebuilding-after-doge-former-regulators-speaking-out/ via @statnews.com
0 boosts · 0 favs · 0 replies · May 7, 2026